ConductScience.org, home

Library / Trials

Exercise, Hypoxia and CPC in TBI Patients

NCT02083445, Not applicable, Completed, University of Barcelona

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleExercise, Hypoxia and CPC in TBI PatientsClinicalTrials.gov
NCT numberNCT02083445ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment21 participants, actualClinicalTrials.gov
Lead sponsorUniversity of BarcelonaClinicalTrials.gov
ConditionsTraumatic Brain InjuryClinicalTrials.gov
Interventionscognitive activities, Exercise program, Muscle electro-stimulation, Intermittent hypobaric hypoxiaClinicalTrials.gov
First posted2014-03-11ClinicalTrials.gov
Last updated2014-03-11ClinicalTrials.gov

Registered outcomes 4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange from initial physical stress test at one week post-interventionOne week before and an expected average of one week after the intervention
Physical graded maximum stress tests are performed on a cycle ergometer controlling the workload, in order to evaluate physical capacity and adaptation to different intensities of effort.While performance of these tests are conducted, cardiocirculatory (control of heart rate, blood pressure measurement, continuous ECG) and respiratory (breathing gases analysis) are monitored to observe the adaptation to the effort.
ClinicalTrials.gov
PrimaryChange from initial psychological test at one weeks after interventionOne week before and an average of one week after the intervention
Psychological tests evaluated features of language and work (verbal memory-RAVLT), Trail Making Test (TMT A and B), Stroop Test, working memory capacity and attention (WAIS III), information processing speed (WAIS III), orientation and verbal fluency (Barcelona test), executive functions (WAIS III and Tower of London tests) and estimated premorbid intelligence index (vocabulary, WAIS III). Reduced Paced Auditory Serial Addition Test (PASAT-G)
ClinicalTrials.gov
SecondaryCirculating progenitor cells increaseThe day before, every 15 days during the intervention and two weeks after the interventionBlood CD34 staining and flow cytometry assay in accordance with ISHAGE guidelines (Keeney et al., 1998). CD34 cells/µL.ClinicalTrials.gov
OtherRelationship between circulating progenitor cells and physical or psychological tests improvementAn average of two weeks after interventionIf a statistically significant increase of circulating progenitor cells occurs and physical and/or psychological tests improvement, their relationship will be analyzedClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 13

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
12436266BACKGROUNDPubMed
16098951BACKGROUNDPubMed
17581219BACKGROUNDPubMed
18236198BACKGROUNDPubMed
18781504BACKGROUNDPubMed
19205956BACKGROUNDPubMed
19226208BACKGROUNDPubMed
19797690BACKGROUNDPubMed
19874615BACKGROUNDPubMed
20448032BACKGROUNDPubMed
22410278BACKGROUNDPubMed
23272272BACKGROUNDPubMed
24286591BACKGROUNDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 5

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Paced Visual Serial Addition TestPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Tower PlanningPrimary outcomeConductCognition
Trail Making Test APrimary outcomeConductCognition
Verbal FluencyPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)